Property:Inclusion criteria
This is a property of type Text.
B
Brown et al. (2019): Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial +
Pathologically confirmed, unresectable locally advanced or metastatic adenocarcinoma of the colon or rectum with measurable disease per version 1.1 of the Response Evaluation Criteria in Solid Tumors (RECIST) guidelines; patients were eligible if they received prior neoadjuvant or adjuvant chemotherapy or chemoradiation as long as the last dose of treatment was more than 12 months prior to cancer recurrence; Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, normal baseline organ function, and no evidence of hypercalcemia or conditions predisposing to hypercalcemia (ie, hyperparathyroidism). +
Büntzel et al. (2010): Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients +
Patients with squamous cell carcinoma of the head and neck region; atom absorption spectrometry showed a deficiency in selenium and the radiation field included 75% of the major salivary glands +
Büntzel et al. (2010): Selenium Substitution During Radiotherapy of Solid Tumours - Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer Patients +
Patients suffering from gynaecological or head and neck cancer who were irradiated because of their disease +
C
Campos et al. (2011): Guarana (Paullinia cupana) Improves Fatigue in Breast Cancer Patients Undergoing Systemic Chemotherapy +
Adult woman (22-70 years) with Mamma-carcinoma +
Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy +
Completely functional erections before surgery (corroborated by the partner and documented in the patient file), bilateral nerve-sparing radical retropubic prostatectomy (indicated on the surgical report) performed for pathologically proven organ-confined disease at least 6 months before screening, no adjuvant or neoadjuvant therapy for prostate cancer, no other treatment for ED before or after surgery, an undetectable postoperative prostate-specific antigen level, and involvement in a stable heterosexual relationship for at least 6 months before surgery +
Chan et al. (2011): Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer +
Low-burden prostate cancer; choosing active surveillance for disease management; histologically documented prostate adenocarcinoma; extended pattern biopsy within 2 years of enrollment with a Gleason sum six or lower with no pattern four or five; no more than 33% of biopsy cores positive for cancer; no more than 50% of the length of a tumor core involved by carcinoma; three serum prostate-specific antige (PSA) levels done at least 2 weeks apart over the year prior to randomization; all PSA levels <10 ng/ml; life expectancy >3 months; ECOG (Eastern Cooperative Oncology Group) performance score <2 +
Chung et al. (2016): Randomized Trial of Vitamin C/E Complex for Prevention of Radiation- Induced Xerostomia in Patients with Head and Neck Cancer +
Diagnosed with biopsy-proven Head-Neck-Cancer, treated with >4000-cGy intensity-modulated radiotherapy +
Cohen et al. (2018): Favorable Effects of a Ketogenic Diet on Physical Function, Perceived Energy, and Food Cravings in Women with Ovarian or Endometrial Cancer: A Randomized, Controlled Trial +
Women diagnosed with ovarian or endometrial cancer; BMI ≥ 18.5 kg/m2; age ≥ 19 years; no medical condition affecting body weight (other than cancer and its associated treatment); not attempting diet modification; women with type 2 diabetes eligible to participate with additional medical supervision from the study physician +
Crew et al. (2012): Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer +
Women; 21-65 years; history of histologically confirmed resected stage I–III ER negative and progesterone receptor (PR)-negative (defined as <10% ER and PR expression) breast carcinoma; without evidence of disease at trial entry; minimum of 6 months since completion of breast surgery, adjuvant chemotherapy (including trastuzumab), and radiation therapy; Eastern Cooperative Group performance status of 0 to 1; at least one intact breast (no radiation therapy, mastectomy, or breast implant); normal organ and marrow function, including total bilirubin and transaminases within normal institutional limits; Pre- and postmenopausal women: postmenopausal = absence of menses for more than 12 months, history of bilateral oophorectomy, or serum follicle-stimulating hormone (FSH) more than 20 mIU/mL +
Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study +
Moderate to severe fatigue, a Karnofsky Performance Status (KPS) score 14 of 50 or more, and carnitine deficiency; carnitine deficiency was defined as free carnitine less than 35 µmol/L for males or less than 25 µmol/L for females (normal range 35-67 and 25-55, respectively), or an acyl-carnitine ratio of more than 0.4 (acylcarnitine ratio 0.4 total acyl-carnitine - free acyl-carnitine/free acyl-carnitine) +
Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial +
Hemoglobin ≥ 9 g/dL taken ≤ 4 weeks before registration +
Côté et al. (2016): Improving Quality of Life With Nabilone During Radiotherapy Treatments for Head and Neck Cancers: A Randomized Double-Blind Placebo-Controlled Trial +
Histological diagnosis of squamous cell carcinoma of the oral cavity, the oropharynx, the hypopharynx, and/or the larynx; treated by radiotherapy alone, postoperative radiotherapy, radiochemotherapy alone, or postoperative radiochemotherapy; aged 18 to 80 years; no other cancer diagnosis in the past 5 years, except for basal cell and squamous cell carcinoma of the skin +
D
Da Costa et al. (2009): Effectiveness of Guarana (Paullinia cupana) for Postradiation Fatigue and Depression Results of a Pilot Double-Blind Randomized Study +
Patients with a histological diagnosis of early stage breast cancer in an early stage (I or II) for whom adjuvant radiation therapy was indicated +
Dale et al. (2001): Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects +
Women between 24-85 years; locally advanced, biopsy-confirmed carcinomas of the uterine cervix at stages Ib, IIb or IIIb +
Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 +
Had undergone near-total thyroidectomy for DTC (differentiated thyroid cancer), at enrollment considered to be free of cancer metastases (serum thyroglubin level < 10ng/ml, negative anti-TG antibody titer and negative ultrasound neck examination +
Del Giglio (2013): Purified Dry Extract of Paullinia cupana (Guarana) (PC-18) for Chemotherapy-Related Fatigue in Patients with Solid Tumors: An Early Discontinuation Study +
Adults with a histological diagnosis of cancer at any stage who were receiving systemic chemotherapy. +
Delanian et al. (2003): Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis +
Women who had had radiotherapy for breast cancer and exhibited clinically measurable radiation induced fibrosis that had occurred more than 6 months after radiotherapy completion, without evidence of recurrent or evolutionary cancer or skin pathology +
Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study +
Cancer patients, age ≥ 18 years, chemotherapy with cisplatin +
Dos Santos Martins (2016): Placebo-Controlled, Double-Blind, Randomized Study of a Dry Guarana Extract in Patients with Head and Neck Tumors Undergoing Chemoradiotherapy: Effects on Fatigue and Quality of Life +
Patients with localized or locally advanced head and neck cancer (stage I - IV) with indications for chemoradiotherapy, with or without surgical treatment or prior induction chemotherapy. +
Dyer et al. (2013): Is reflexology as effective as aromatherapy massage for symptom relief in an adult outpatient oncology population? +
Patients over 18 years old, with a diagnosis of cancer, attending the hospital as NHS out- patients, wishing to access complementary therapy treatment and able to attend the hospital for four, one-hour sessions. +